Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-22), Intelligent Bio Solutions's 3-1 Month Momentum % is -31.18%.
The industry rank for Intelligent Bio Solutions's 3-1 Month Momentum % or its related term are showing as below:
INBS's 3-1 Month Momentum % is ranked worse than 87.07% of 843
companies
in the Medical Devices & Instruments industry
Industry Median: -6.48
vs INBS: -31.18
Intelligent Bio Solutions (NAS:INBS) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Intelligent Bio Solutions 3-1 Month Momentum % Related Terms
INBS vs RMSL, USAQ, ITOC: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Intelligent Bio Solutions's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's 3-1 Month Momentum % falls into.
Intelligent Bio Solutions (NAS:INBS) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions (INBS) has a 3-1 Month Momentum % of -31.18% as of Aug. 22, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Intelligent Bio Solutions and its competitors. According to the industry distribution chart, Intelligent Bio Solutions ranks #734 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 87.1%.
Is Intelligent Bio Solutions' 3-1 Month Momentum % too high?
Intelligent Bio Solutions' current 3-1 Month Momentum % is -31.18%. Based on the distribution chart, Intelligent Bio Solutions ranks #734 out of 843 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' 3-1 Month Momentum % compare to RMSL and USAQ?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #734 out of 843 companies for 3-1 Month Momentum %. This places Intelligent Bio Solutions in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Intelligent Bio Solutions and its competitors. Intelligent Bio Solutions's current 3-1 Month Momentum % is -31.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Fairly Valued. The stock's GF Value™ is $2.73, compared to a current price of $2.48 — trading 9.3% below its estimated fair value. The current 3-1 Month Momentum % is -31.18%. Intelligent Bio Solutions' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current 3-1 Month Momentum % is -31.18% as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intelligent Bio Solutions (INBS) Overvalued in 2026?
Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued.
The current stock price of $2.48 is trading 9.3% below its estimated GF Value™ of $2.73.
GuruFocus considers Intelligent Bio Solutions to be Fairly Valued.
Key valuation signals for INBS:
3-1 Month Momentum %: -31.18%
GF Value™: $2.73 vs. price of $2.48 (9.3% below fair value)
No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
50GF Score
Get the complete analysis for INBS
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INBS has been successfully added to your 
